Francesco Tovoli
www.unibo.it
0000-0002-8350-1155
University of Bologna
29 papers found
Refreshing results…
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy
Autoimmune Polyendocrine Syndromes in Adult Italian Celiac Disease Patients
Genetic, Immunological, Dietary, Gut Microbiota, and Environmental Determinants of Osteoporosis in the Course of Celiac Disease: Which Factor Plays the First Violin in This Orchestra?
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma
TKIs in combination with immunotherapy for hepatocellular carcinoma
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival
COVID-19: Has the Liver Been Spared?
Radiological Features of Microvascular Invasion of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool?
Does aspirin use influence hepatocellular carcinoma and cholangiocarcinoma prognosis?
Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers
Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma
Missing publications? Search for publications with a matching author name.